BMC Medicine (Feb 2019)
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
- Michael Berk,
- Alyna Turner,
- Gin S. Malhi,
- Chee H. Ng,
- Susan M. Cotton,
- Seetal Dodd,
- Yuval Samuni,
- Michelle Tanious,
- Claire McAulay,
- Nathan Dowling,
- Jerome Sarris,
- Lauren Owen,
- Astrid Waterdrinker,
- Deidre Smith,
- Olivia M. Dean
Affiliations
- Michael Berk
- IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University
- Alyna Turner
- IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University
- Gin S. Malhi
- CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District
- Chee H. Ng
- Department of Psychiatry, University of Melbourne, the Melbourne Clinic
- Susan M. Cotton
- Orygen, The National Centre of Excellence in Youth Mental Health
- Seetal Dodd
- IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University
- Yuval Samuni
- IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University
- Michelle Tanious
- CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District
- Claire McAulay
- CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District
- Nathan Dowling
- Department of Psychiatry, University of Melbourne, the Melbourne Clinic
- Jerome Sarris
- Department of Psychiatry, University of Melbourne, the Melbourne Clinic
- Lauren Owen
- School of Psychology, University of Central Lancashire
- Astrid Waterdrinker
- Melbourne Health
- Deidre Smith
- Department of Psychiatry, University of Melbourne, the Melbourne Clinic
- Olivia M. Dean
- IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University
- DOI
- https://doi.org/10.1186/s12916-019-1280-2
- Journal volume & issue
-
Vol. 17,
no. 1
pp. 1 – 1
Abstract
The original article [1] contained two minor errors.
